- Opened 565,000 sq. ft. fully automated state-of-art distribution center in East Windsor, NJ
- Opened a new, 40,000 sq. ft. specialty pharma R&D facility in Durham, NC
- APL acquired 4 cell culture-derived biosimilar products from Swiss TL Biopharmaceutical. Three out of the four biosimilars are monoclonal antibodies in oncology.
- APL acquires Portugal’s Generis Farmaceutica SA